We are live on ! Find out more
CATX icon

Perspective Therapeutics
CATX

42 hedge funds and large institutions have $17.8M invested in Perspective Therapeutics in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 9 increasing their positions, 6 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

317% more capital invested

Capital invested by funds: $4.26M → $17.8M (+$13.5M)

50% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 6

0.21% less ownership

Funds ownership: 1.21% → 1% (-0.21%)

13% less funds holding

Funds holding: 48 → 42 (-6)

46% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 13

Holders
42
Holders Change
-6
Holders Change %
-12.5%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
9
Reduced
6
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.43M
2
BlackRock
BlackRock
New York
+$1.04M
3
OCM
Osterweis Capital Management
California
+$646K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$295K
5
Northern Trust
Northern Trust
Illinois
+$61.5K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$75.5K
2
UBS Group
UBS Group
Switzerland
-$32.4K
3
VF
Virtu Financial
New York
-$17K
4
Jane Street
Jane Street
New York
-$12.2K
5
PCM
Perkins Capital Management
Minnesota
-$9.39K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wells Fargo
26
Wells Fargo
California
$17.4K +$8.56K +2,096 +335%
Royal Bank of Canada
27
Royal Bank of Canada
Ontario, Canada
$16K +$16 +4 +0.2%
TWM
28
TMD Wealth Management
Arizona
$12.8K – – –
WAOI
29
Wealth Advisors of Iowa
Iowa
$12.8K – – –
RJFSA
30
Raymond James Financial Services Advisors
Florida
$11.2K – – –
Ameriprise
31
Ameriprise
Minnesota
$9.57K – – –
AAM
32
Auxier Asset Management
Oregon
$9.07K – – –
GVAG
33
Great Valley Advisor Group
Delaware
$7.66K – – –
CAI
34
Capital Advisors Inc
Oklahoma
$6.38K – – –
TRCT
35
Tower Research Capital (TRC)
New York
$4K -$6.05K -1,481 -69%
UBS Group
36
UBS Group
Switzerland
$3.19K -$32.4K -7,930 -94%
JFA
37
JNBA Financial Advisors
Minnesota
$3.19K – – –
TWC
38
TD Waterhouse Canada
Ontario, Canada
$1.35K – – –
ASN
39
Advisory Services Network
Georgia
$638 – – –
CCM
40
Chilton Capital Management
Texas
$319 +$204 +50 New
BNP Paribas Financial Markets
41
BNP Paribas Financial Markets
France
$101 +$65 +16 New
Commonwealth Equity Services
42
Commonwealth Equity Services
Massachusetts
$27 +$6.94K +1,700 +65%
Citadel Advisors
43
Citadel Advisors
Florida
– -$75.5K -30,564 Closed
VF
44
Virtu Financial
New York
– -$17K -6,700 Closed
Jane Street
45
Jane Street
New York
– -$12.2K -4,944 Closed
HF
46
HRT Financial
New York
– -$7K -3,019 Closed
BBNA
47
Bremer Bank National Association
Minnesota
– -$7K -2,941 Closed
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
– -$4.78K -1,935 Closed
TSS
49
Two Sigma Securities
New York
– -$4.03K -1,633 Closed
Victory Capital Management
50
Victory Capital Management
Texas
– -$3.94K -1,596 Closed
1
2
3

CATX Hedge Fund Activity: Q1 2023 in Review

42 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Perspective Therapeutics (CATX) for Q1 2023, worth a combined $17.8M — up 317% from $4.26M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of CATX and 7 opened new positions — a net loss of 6 holders — while 6 trimmed existing stakes and 9 added.

The largest buyer was Vanguard Group, adding an estimated $2.43M. The largest seller was Citadel Advisors, exiting entirely with an estimated $75.5K sold.

  • 42 institutional investors held Perspective Therapeutics (CATX) as of Q1 2023, down from 48 in Q4 2022.
  • Funds reported $17.8M of Perspective Therapeutics stock for Q1 2023, up 317% quarter-over-quarter.
  • 7 funds opened new Perspective Therapeutics positions in Q1 2023 and 13 closed out, a net change of -6 holders.
  • The largest Perspective Therapeutics buyer in Q1 2023 was Vanguard Group, an estimated $2.43M added.
  • The largest Perspective Therapeutics seller in Q1 2023 was Citadel Advisors, an estimated $75.5K sold.

Based on aggregated 13F filings for Q1 2023.